The DOI matches its Crossref record; 421 of the 427 references it cites were found in a registry or an index.
Cost of disorders of the brain in Europe 2010
Open accessAbstract
Background The spectrum of disorders of the brain is large, covering hundreds of disorders that are listed in either the mental or neurological disorder chapters of the established international diagnostic classification systems. These disorders have a high prevalence as well as short- and long-term impairments and disabilities. Therefore they are an emotional, financial and social burden to the patients, their families and their social network. In a 2005 landmark study, we estimated for the first time the annual cost of 12 major groups of disorders of the brain in Europe and gave a conservative estimate of €386 billion for the year 2004. This estimate was limited in scope and conservative due to the lack of sufficiently comprehensive epidemiological and/or economic data on several important diagnostic groups. We are now in a position to substantially improve and revise the 2004 estimates. In the present report we cover 19 major groups of disorders, 7 more than previously, of an increased range of age groups and more cost items. We therefore present much improved cost estimates. Our revised estimates also now include the new EU member states, and hence a population of 514 million people.Aims To estimate the number of persons with defined disorders of the brain in Europe in 2010, the total cost per person related to each disease in terms of direct and indirect costs, and an estimate of the total cost per disorder and country.Methods The best available estimates of the prevalence and cost per person for 19 groups of disorders of the brain (covering well over 100 specific disorders) were identified via a systematic review of the published literature. Together with the twelve disorders included in 2004, the following range of mental and neurologic groups of disorders is covered: addictive disorders, affective disorders, anxiety disorders, brain tumor, childhood and adolescent disorders (developmental disorders), dementia, eating disorders, epilepsy, mental retardation, migraine, multiple sclerosis, neuromuscular disorders, Parkinson's disease, personality disorders, psychotic disorders, sleep disorders, somatoform disorders, stroke, and traumatic brain injury. Epidemiologic panels were charged to complete the literature review for each disorder in order to estimate the 12-month prevalence, and health economic panels were charged to estimate best cost-estimates. A cost model was developed to combine the epidemiologic and economic data and estimate the total cost of each disorder in each of 30 European countries (EU27+Iceland, Norway and Switzerland). The cost model was populated with national statistics from Eurostat to adjust all costs to 2010 values, converting all local currencies to Euro, imputing costs for countries where no data were available, and aggregating country estimates to purchasing power parity adjusted estimates for the total cost of disorders of the brain in Europe 2010.Results The total cost of disorders of the brain was estimated at €798 billion in 2010. Direct costs constitute the majority of costs (37% direct healthcare costs and 23% direct non-medical costs) whereas the remaining 40% were indirect costs associated with patients' production losses. On average, the estimated cost per person with a disorder of the brain in Europe ranged between €285 for headache and €30,000 for neuromuscular disorders. The European per capita cost of disorders of the brain was €1550 on average but varied by country. The cost (in billion €PPP 2010) of the disorders of the brain included in this study was as follows: addiction: €65.7; anxiety disorders: €74.4; brain tumor: €5.2; child/adolescent disorders: €21.3; dementia: €105.2; eating disorders: €0.8; epilepsy: €13.8; headache: €43.5; mental retardation: €43.3; mood disorders: €113.4; multiple sclerosis: €14.6; neuromuscular disorders: €7.7; Parkinson's disease: €13.9; personality disorders: €27.3; psychotic disorders: €93.9; sleep disorders: €35.4; somatoform disorder: €21.2; stroke: €64.1; traumatic brain injury: €33.0. It should be noted that the revised estimate of those disorders included in the previous 2004 report constituted €477 billion, by and large confirming our previous study results after considering the inflation and population increase since 2004. Further, our results were consistent with administrative data on the health care expenditure in Europe, and comparable to previous studies on the cost of specific disorders in Europe. Our estimates were lower than comparable estimates from the US.Discussion This study was based on the best currently available data in Europe and our model enabled extrapolation to countries where no data could be found. Still, the scarcity of data is an important source of uncertainty in our estimates and may imply over- or underestimations in some disorders and countries. Even though this review included many disorders, diagnoses, age groups and cost items that were omitted in 2004, there are still remaining disorders that could not be included due to limitations in the available data. We therefore consider our estimate of the total cost of the disorders of the brain in Europe to be conservative. In terms of the health economic burden outlined in this report, disorders of the brain likely constitute the number one economic challenge for European health care, now and in the future. Data presented in this report should be considered by all stakeholder groups, including policy makers, industry and patient advocacy groups, to reconsider the current science, research and public health agenda and define a coordinated plan of action of various levels to address the associated challenges.Recommendations Political action is required in light of the present high cost of disorders of the brain. Funding of brain research must be increased; care for patients with brain disorders as well as teaching at medical schools and other health related educations must be quantitatively and qualitatively improved, including psychological treatments. The current move of the pharmaceutical industry away from brain related indications must be halted and reversed. Continued research into the cost of the many disorders not included in the present study is warranted. It is essential that not only the EU but also the national governments forcefully support these initiatives.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The economic costs of headaches are substantial, primarily manifesting as indirect and intangible costs. This includes work absences because of headaches (absenteeism), reduced on-the-job performance while experiencing headaches (presenteeism), reduced quality of life, and increased pain outside the workplace [5-7].”
In the citing paper
“Persistent depressive disorder (PDD) is characterized by psychosocial impairment (Angst et al. 2009; Gustavsson et al. 2011; Klein et al. 1988), high comorbidity (Köhler et al. 2019), low rates of spontaneous remission (McCullough et al. 1988) and poorer treatment outcomes compared to episodic depression (Stewart et al. 1989; Thase et al. 1994).”
From Reciprocal Dynamics of Therapeutic Alliance and Depressive Symptoms in Inpatient Cognitive Behavioural Analysis System of Psychotherapy: The Role of Attachment Insecurity. (2025) · cites this paper as Gustavsson et al. 2011
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,656
The Occurrence of Sleep-Disordered Breathing among Middle-Aged Adults
Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S., & Badr, S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304293281704 · Cited by 10,183
Epidemiology of Obstructive Sleep Apnea: A Population Health Perspective
Young, T., Peppard, P. E., & Gottlieb, D. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2109080 · Cited by 4,244
Estimates of the cancer incidence and mortality in Europe in 2006
Ferlay, J., Autier, P., Boniol, M., Heanue, M., Colombet, M., & Boyle, P. (2007) · Annals of Oncology · doi:10.1093/annonc/mdl498 · Cited by 4,032
Comprehensive Textbook of Psychiatry
Freedman, A. M., & Kaplan, H. I. (1967) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196712000-00052 · Cited by 3,825
The size and burden of mental disorders and other disorders of the brain in Europe 2010
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754
Self-citationOosterhuis, H. (1997) · Cited by 2,397
Estimates of cancer incidence and mortality in Europe in 2008
Ferlay, J., Parkin, D. M., & Steliarova‐Foucher, E. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.12.014 · Cited by 2,323
Epidemiology of Pervasive Developmental Disorders
Fombonne, E. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819e7203 · Cited by 1,971
Research works printed but not linked: 8
- Atance Martinez, 2004, Costs study in Alzheimer's disease, Rev. Clin. Esp., 204, 64
- Bertelli, 2009, New contributions of psychiatric research in the field of intellectual disabilities, Adv. Psychiatry, 3, 37
- Cavallo, 1997, The economic and social burden of Alzheimer disease on families in the Lombardy region of Italy, Alzheimer Dis. Assoc. Disord., 11, 184
- Gessner, 1993, The cost of epilepsy in Switzerland, Int. J. Health Sci., 4, 121
- Mahdi-Rogers, 2008, Epidemiology and treatment of chronic inflammatory neuropathies in South East England, Eur. J. Neurol., 15
- Salize, 2004, Cost of care for depressive disorders in primary and specialized care in Germany, Psychiatr. Prax., 31, 147
- Wilms, 2004, Illness related costs for spouses of patients suffering from a mental illness: results of a study with repeated measurements, Psychiatr. Prax., 31, 177
- Wittchen, 2010, The timing of depression: an epidemiological perspective, Medicographia, 32, 155-125
Cited by
Sorted by citations
Items 201–300 of 1,008
Suicide in Stroke Survivors: Epidemiology and Prevention
Pompili, M., Venturini, P., Lamis, D. A., Giordano, G., Serafini, G., Murri, M. B., Amore, M., & Girardi, P. (2014) · Drugs & Aging · doi:10.1007/s40266-014-0233-x · Cited by 87
A literature review of indirect costs associated with stroke
Joo, H., George, M., Fang, J., & Wang, G.-J. (2014) · Journal of Stroke & Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2014.02.017 · Cited by 90
Schröder, J., Truijen, S., Criekinge, T. V., & Saeys, W. (2018) · Journal of Rehabilitation Medicine · doi:10.2340/16501977-2505 · Cited by 85
Intolerance of uncertainty in eating disorders: an update on the field
Kesby, A., Maguire, S., Brownlow, R., & Grisham, J. R. (2017) · Clinical Psychology Review · doi:10.1016/j.cpr.2017.07.002 · Cited by 83
Kinetic modelling of serum S100b after traumatic brain injury
Ercole, A., Thelin, E. P., Holst, A., Bellander, B., & Nelson, D. (2016) · BMC Neurology · doi:10.1186/s12883-016-0614-3 · Cited by 84
Evaluation of health-care utilization among adult patients with epilepsy in Germany
Strzelczyk, A., Nickolay, T., Bauer, S., Haag, A., Knake, S., Oertel, W. H., Reif, P. S., Rosenow, F., Reese, J. P., Dodel, R. C., et al. (2012) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2012.01.021 · Cited by 84
Self-citationChevreul, K., Durand‐Zaleski, I., Gouépo, A., Féry-Lemonnier, É., Hommel, M., & Woimant, F. (2013) · European Journal of Neurology · doi:10.1111/ene.12143 · Cited by 84
Economic aspects of the association between diabetes and depression: A systematic review
Mosweu, I., Patel, A. K., Gagliardino, J. J., Knapp, M. R. J., & McDaid, D. (2012) · Journal of Affective Disorders · doi:10.1016/s0165-0327(12)70008-3 · Cited by 90
Self-citationExpenditure on retail pharmaceuticals per capita, 2016
(2018) · Health at a glance. Europe · doi:10.1787/health_glance_eur-2018-graph85-en · Cited by 83
Prokop, A. (2013) · Neural Development · doi:10.1186/1749-8104-8-17 · Cited by 84
Kortland, L., Alfter, A., Bähr, O., Carl, B., Dodel, R. C., Freiman, T. M., Hubert, K., Jahnke, K., Knake, S., von Podewils, F., et al. (2016) · Epilepsia · doi:10.1111/epi.13584 · Cited by 82
Self-citationLatapy, C., Rioux, V., Guitton, M. J., & Beaulieu, J. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2012.0094 · Cited by 84
Integrated care in patients with schizophrenia
Schöttle, D., Karow, A., SCHIMMELMANN, B. G., & Lambert, M. (2013) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328361ec3b · Cited by 81
Chiu, C., Bishop, M. L., Pionke, J., Strauser, D. R., & Santens, R. (2017) · International Journal of MS Care · doi:10.7224/1537-2073.2016-016 · Cited by 81
Mowry, B. J., & Gratten, J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.34 · Cited by 82
Thapa, D. K., Visentin, D. C., Kornhaber, R. A., & Cleary, M. L. (2020) · Nursing and Health Sciences · doi:10.1111/nhs.12783 · Cited by 93
Molecular Mechanisms of Drug Action: An Emerging View
Sonner, J. M., & Cantor, R. S. (2013) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-083012-130341 · Cited by 79
Geerts, H., Dacks, P. A., Devanarayan, V., Haas, M., Khachaturian, Z. S., Gordon, M. F., Maudsley, S. R., Romero, K., Stephenson, D. T., & (BHMI), B. H. M. I. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.04.008 · Cited by 79
Time for mental health to come out of the shadows
Kleinman, A., Estrin, G. L., Usmani, S., Chisholm, D., Marquez, P. V., Evans, T. G., & Saxena, S. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30655-9 · Cited by 79
Effertz, T., & Mann, K. F. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.07.010 · Cited by 79
Functional connectivity density alterations in schizophrenia
Zhuo, C., Zhu, J., Qin, W., Qu, H., Ma, X., Tian, H., Xu, Q., & Yu, C. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00404 · Cited by 82
Leichsenring, F., & Salzer, S. (2013) · Psychotherapy · doi:10.1037/a0033815 · Cited by 81
The increasing burden of mental and neurological disorders
Catalá-López, F., Gènova-Maleras, R., Vieta, E., & Tabarés‐Seisdedos, R. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.04.001 · Cited by 79
Jennum, P., Iversen, H. K., Ibsen, R., & Kjellberg, J. (2015) · BMC Health Services Research · doi:10.1186/s12913-015-1100-0 · Cited by 79
Self-citationSeven challenges for neuroscience.
Markram, H. (2013) · Europe PMC (PubMed Central) · doi:10.11138/fneur/2013.28.3.145 · Cited by 78
de Heer, E. W., ten Have, M., van Marwijk, H., Dekker, J., de Graaf, R., Beekman, A. T. F., & Feltz-Cornelis, C. M. V. D. (2017) · Pain · doi:10.1097/j.pain.0000000000001133 · Cited by 77
Manandhar, K., Risal, A., Shrestha, O., Manandhar, N., Kunwar, D., Koju, R., & Holen, A. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2258-5 · Cited by 77
Maranesi, E., Casoni, E., Baldoni, R., Barboni, I., Rinaldi, N., Tramontana, B., Amabili, G., Benadduci, M., Barbarossa, F., Luzi, R., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192214818 · Cited by 95
Weeks, W. B., Ventelou, B., & Paraponaris, A. (2015) · The European Journal of Health Economics · doi:10.1007/s10198-015-0692-y · Cited by 77
Meulders, A., Daele, T. V., Volders, S., & Vlaeyen, J. W. S. (2016) · Clinical Psychology Review · doi:10.1016/j.cpr.2016.02.002 · Cited by 83
Kobelt, G., Langdon, D. W., & Jönsson, L. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518769837 · Cited by 76
Self-citationBosman, R. C., Huijbregts, K. M., Verhaak, P. F., Ruhé, H. G., van Marwijk, H. W., van Balkom, A. J., & Batelaan, N. M. (2016) · British Journal of General Practice · doi:10.3399/bjgp16x686641 · Cited by 76
DETECTION OF ANXIETY DISORDERS IN PRIMARY CARE: A META-ANALYSIS OF ASSISTED AND UNASSISTED DIAGNOSES
Olariu, E., Forero, C. G., Castro-Rodríguez, J. I., Rodrigo‐Calvo, M. T., Álvarez, P., Martín‐Lopez, L. M., Sánchez-Toto, A., Adroher, N. D., Blasco, M. J., Vilagut, G., et al. (2015) · Depression and Anxiety · doi:10.1002/da.22360 · Cited by 91
Self-citationReducing Ventral Tegmental Dopamine D2 Receptor Expression Selectively Boosts Incentive Motivation
de Jong, J. W., Roelofs, T. J. M., Mol, F., Hillen, A. E. J., Meijboom, K. E., Luijendijk, M. C. M., van der Eerden, H. A. M., Garner, K. M., Vanderschuren, L. J. M. J., & Adan, R. A. H. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.60 · Cited by 77
Hip fracture surgery initiation after admission to the hospital, 2015 (or nearest year)
(2018) · Health at a glance. Europe · doi:10.1787/health_glance_eur-2018-graph104-en · Cited by 76
P2X7 Receptor-Associated Programmed Cell Death in the Pathophysiology of Hemorrhagic Stroke
Zhao, H., Chen, Y., & Feng, H. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180516094500 · Cited by 74
Do We Need to Rethink the Epidemiology and Healthcare Utilization of Parkinson's Disease in Germany?
Heinzel, S., Berg, D., Binder, S., Ebersbach, G., Hickstein, L., Herbst, H., Lorrain, M., Wellach, I., Maetzler, W., Petersen, G., et al. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00500 · Cited by 75
Identifying biological markers for improved precision medicine in psychiatry
Quinlan, E. B., Banaschewski, T., Barker, G. J., Bokde, A. L. W., Bromberg, U., Büchel, C., Desrivières, S., Flor, H., Frouin, V., Garavan, H., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0555-5 · Cited by 74
Medicines for the Mind: Policy-Based “Pull” Incentives for Creating Breakthrough CNS Drugs
Choi, D. W., Armitage, R., Brady, L. S., Coetzee, T., Fisher, W. W., Hyman, S. E., Pande, A. C., Paul, S. M., Potter, W. Z., Roin, B. N., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.10.027 · Cited by 77
The known and missing links between Toxoplasma gondii and schizophrenia
Elsheikha, H., Büsselberg, D., & Zhu, X.-Q. (2016) · Metabolic brain disease · doi:10.1007/s11011-016-9822-1 · Cited by 70
The Treatment of Depression in Primary Care
Trautman, S., & Beesdo‐Baum, K. (2017) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2017.0721 · Cited by 81
Adolescent mental health and unemployment over the lifespan: Population evidence from Sweden
Mousteri, V., Daly, M., Delaney, L. D., Tynelius, P., & Rasmussen, F. E. (2019) · Social Science & Medicine · doi:10.1016/j.socscimed.2018.12.030 · Cited by 73
The course of cancer-related insomnia: don't expect it to disappear after cancer treatment
Schieber, K., Niecke, A., Geiser, F., Erim, Y., Bergelt, C., Büttner‐Teleagă, A., Maatouk, I., Stein, B., Teufel, M., Wickert, M., et al. (2019) · Sleep Medicine · doi:10.1016/j.sleep.2019.02.018 · Cited by 80
Meegan, A. P., Perry, I. J., & Phillips, C. M. (2017) · Nutrients · doi:10.3390/nu9030238 · Cited by 73
Inpatient treatment costs of status epilepticus in adults in Germany
Strzelczyk, A., Knake, S., Oertel, W. H., Rosenow, F., & Hamer, H. M. (2013) · Seizure · doi:10.1016/j.seizure.2013.08.003 · Cited by 72
Bramness, J. G., Henriksen, B., Person, O., & Mann, K. F. (2013) · European Addiction Research · doi:10.1159/000348260 · Cited by 72
Expert Opinion: Managing sleep disturbances in people with epilepsy
Nobili, L., Beniczky, S., Eriksson, S., Romigi, A., Ryvlin, P., Toledo, M., & Rosenzweig, I. (2021) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2021.108341 · Cited by 78
Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine
Pakpoor, J., Handel, A. E., Giovannoni, G., Dobson, R., & Ramagopalan, S. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045295 · Cited by 72
Epidemiology and costs of depressive disorder in Spain: the EPICO study
Vieta, E., Alonso, J., Pérez-Sola, V., Roca, M., Hernando, T., Sicras-Mainar, A., Sicras-Navarro, A., Herrera, B., & Gabilondo, A. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.04.022 · Cited by 70
Self-citationImpaired reward-related learning signals in remitted unmedicated patients with recurrent depression
Geugies, H., Mocking, R. J. T., Figueroa, C. A., Groot, P. F. C., Marsman, J.-B. C., Servaas, M. N., Steele, J. D., Schene, A. H., & Ruhé, H. G. (2019) · Brain · doi:10.1093/brain/awz167 · Cited by 67
Vis, C., Kleiboer, A., Prior, R., Bønes, E., Cavallo, M., Clark, S. A., Dozeman, E., Ebert, D., Etzelmueller, A., Favaretto, G., et al. (2015) · Internet Interventions · doi:10.1016/j.invent.2015.10.002 · Cited by 71
The multidimensional burden of informal caregivers in primary malignant brain tumor
Bayen, E., Laigle-Donadey, F., Prouté, M., Hoang-Xuan, K., Joël, M.-E., & Delattre, J.-Y. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-016-3397-6 · Cited by 82
Jennum, P., Ibsen, R., & Kjellberg, J. (2013) · European Respiratory Journal · doi:10.1183/09031936.00169212 · Cited by 74
Self-citationScaratti, C., Leonardi, M., Sattin, D., Schiavolin, S., Willems, M., & Raggi, A. (2016) · Disability and Rehabilitation · doi:10.3109/09638288.2016.1162854 · Cited by 71
Chen, W., Li, H., Liu, Z., & Yuan, W. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00068 · Cited by 74
Smith, K. (2011) · Nature · doi:10.1038/478015a · Cited by 71
Costs and quality of life in multiple sclerosis patients with spasticity
Svensson, J., Borg, S., & Nilsson, P. C. (2013) · Acta Neurologica Scandinavica · doi:10.1111/ane.12139 · Cited by 70
Treatment of Eating Disorders can not Remain ‘Brainless’: The Case for Brain‐Directed Treatments
Schmidt, U. H., & Campbell, I. C. (2013) · European Eating Disorders Review · doi:10.1002/erv.2257 · Cited by 70
The Impact of Alexithymia on Treatment Response in Psychiatric Disorders: A Systematic Review
Pinna, F., Manchia, M., Paribello, P., & Carpiniello, B. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00311 · Cited by 69
Healthy minds 0–100 years: Optimising the use of European brain imaging cohorts (“Lifebrain”)
Walhovd, K., Fjell, A., Westerhausen, R., Nyberg, L., Ebmeier, K. P., Lindenberger, U., Bartrés-Faz, D., Baaré, W., Siebner, H., Henson, R., et al. (2018) · European psychiatry · doi:10.1016/j.eurpsy.2017.12.006 · Cited by 64
Current Pharmacological Treatments for ADHD
Groom, M. J., & Cortese, S. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_330 · Cited by 74
School Intervention to Improve Mental Health of Students in Santiago, Chile
Araya, R., Rosemarie Fritsch, M., Spears, M. R., Rojas, G., Martínez, V., Barroilhet, S. A., Vöhringer, P. A., Gunnell, D., Stallard, P. N., Viviana Guajardo, T., et al. (2013) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2013.2361 · Cited by 68
Bloem, B. R., & Stocchi, F. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03532.x · Cited by 68
Ilie, G., Adlaf, E. M., Mann, R. E., Ialomiteanu, A., Hamilton, H. A., Rehm, J. T., Asbridge, M., & Cusimano, M. D. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2014.3619 · Cited by 68
Self-citationAntunes, A., Frasquilho, D., Lopes, S. A., Neto, D., Silva, M., Cardoso, G., & Caldas‐de‐Almeida, J. M. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2017.12.004 · Cited by 67
Mohseni, M., Sahebkar, A., Askari, G., Johnston, T. P., Alikiaii, B., & Bagherniya, M. (2021) · Phytotherapy Research · doi:10.1002/ptr.7273 · Cited by 70
Kröger, C. B., Bode, K., Wunsch, E., Kliem, S., Grocholewski, A., & Finger, F. (2014) · Journal of Occupational Health Psychology · doi:10.1037/a0038341 · Cited by 67
Siewert, K. M., Klarin, D. M., Damrauer, S. M., Chang, K., Tsao, P. S., Assimes, T. L., Smith, G. D., Voight, B. F., Gormley, P., Anttila, V., et al. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyaa050 · Cited by 67
Self-citationTherapeutic potential of glutathione-enhancers in stress-related psychopathologies
Zalachoras, I., Hollis, F., Ramos‐Fernández, E., Trovò, L., Sonnay, S., Geiser, E., Preitner, N., Steiner, P., Sandi, C., & Morató, L. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.03.015 · Cited by 69
Heurich, M., Föcking, M., Mongan, D., Cagney, G., & Cotter, D. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01197-9 · Cited by 68
Fear the serpent: A psychometric study of snake phobia
Polák, J., Sedláčková, K., Nácar, D., Landová, E., & Frynta, D. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.05.024 · Cited by 66
Schultze‐Lutter, F., Michel, C., Ruhrmann, S., & SCHIMMELMANN, B. G. (2017) · Psychological Medicine · doi:10.1017/s0033291717002586 · Cited by 69
Breasail, M. Ó., Biswas, B., Smith, M. D., Mazhar, M. K. A., Tenison, E., Cullen, A., Lithander, F. E., Roudaut, A., & Henderson, E. J. (2021) · Sensors · doi:10.3390/s21248261 · Cited by 71
Pedrini, L., Meloni, S., Lanfredi, M., & Rossi, R. (2022) · Journal of Adolescence · doi:10.1002/jad.12090 · Cited by 128
de Roos, P., Bloem, B. R., Kelley, T. A., Antonini, A., Dodel, R. C., Hagell, P., Marras, C., Martínez‐Martín, P., Mehta, S. H., Odin, P., et al. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-161055 · Cited by 68
Self-citationImportance of oral health in mental health disorders: An updated review
Skallevold, H. E., Rokaya, N., Wongsirichat, N., & Rokaya, D. (2023) · Journal of Oral Biology and Craniofacial Research · doi:10.1016/j.jobcr.2023.06.003 · Cited by 72
Giuliani, D., Bitto, A., Galantucci, M., Zaffe, D., Ottani, A., Irrera, N., Neri, L., Cavallini, G. M., Altavilla, D., Botticelli, A. R., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.030 · Cited by 64
Evaluating the economic impact of screening and treatment for depression in the workplace
Evans-Lacko, S. E., Koeser, L., Knapp, M. R. J., Longhitano, C., Zohar, J., & Kuhn, K. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.03.005 · Cited by 70
Self-citationA dynamic course of T cell defects in individuals at risk for mood disorders
Snijders, G. J. L., Schiweck, C., Mesman, E., Grosse, L., de Wit, H., Nolen, W. A., Drexhage, H. A., & Hillegers, M. H. J. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.05.007 · Cited by 64
A new approach for interpreting Random Forest models and its application to the biology of ageing
Fabris, F., Doherty, A., Palmer, D. H., de Magalhães, J. P., & Freitas, A. A. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty087 · Cited by 64
Willems, L. M., Richter, S., Watermann, N., Bauer, S., Klein, K. M., Reese, J., Schöffski, O., Hamer, H. M., Knake, S., Rosenow, F., et al. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.03.025 · Cited by 64
Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat
Jefsen, O. H., Højgaard, K., Christiansen, S. L., Elfving, B., Nutt, D., Wegener, G., & Müller, H. K. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.15 · Cited by 64
Waliszewska‐Prosół, M., Montisano, D. A., Antolak, M., Bighiani, F., Cammarota, F., Cetta, I., Corrado, M., Ihara, K., Kartamysheva, R., Petrušić, I., et al. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01735-0 · Cited by 66
Recent advances in the prevention of mental disorders
Mendelson, T., & Eaton, W. W. (2018) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-018-1501-6 · Cited by 69
Kählke, F., Buntrock, C., Smit, F., & Ebert, D. D. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00702-w · Cited by 66
Neurobiological candidate endophenotypes of social anxiety disorder
Bas‐Hoogendam, J. M., Blackford, J. U., Brühl, A. B., Blair, K. S., van der Wee, N. J. A., & Westenberg, P. M. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.08.040 · Cited by 68
Wearable and Portable GPS Solutions for Monitoring Mobility in Dementia: A Systematic Review
Cullen, A., Mazhar, M. K. A., Smith, M. D., Lithander, F. E., Breasail, M. Ó., & Henderson, E. J. (2022) · Sensors · doi:10.3390/s22093336 · Cited by 61
Singewald, N., Sartori, S. B., Reif, A., & Holmes, A. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109418 · Cited by 64
Burden and cost of neurological diseases: a European North–South comparison
Raggi, A., & Leonardi, M. (2015) · Acta Neurologica Scandinavica · doi:10.1111/ane.12339 · Cited by 64
Short-term Exposure to Air Pollution and Ischemic Stroke
Toubasi, A. A., & Al-Sayegh, T. (2023) · Neurology · doi:10.1212/wnl.0000000000207856 · Cited by 64
Neurological disorders in the Global Burden of Disease 2010 study
Stovner, L. J., Hoff, J. M., Svalheim, S., & Gilhus, N. E. (2014) · Acta Neurologica Scandinavica · doi:10.1111/ane.12229 · Cited by 60
Self-citationSainio, S., Palomäki, T., Rhode, S., Kauppila, M., Pitkänen, O., Selkälä, T., Tóth, G., Moram, M. A., Kordás, K., Koskinen, J., et al. (2015) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2015.01.059 · Cited by 60
Echeverry, C., Prunell, G., Narbondo, C., de Medina, V. S., Nadal, X., Reyes-Parada, M. I., & Scorza, C. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00277-y · Cited by 64
Bellón, J. Á., Moreno-Peral, P., Motrico, E., Morejón, A. R., Fernández, A., Serrano‐Blanco, A., Zabaleta‐del‐Olmo, E., & Cerón, S. C. (2014) · Preventive Medicine · doi:10.1016/j.ypmed.2014.11.003 · Cited by 59
Social, societal, and economic burden of mal de debarquement syndrome
Macke, A., LePorte, A. D., & Clark, B. C. (2012) · Journal of Neurology · doi:10.1007/s00415-011-6349-6 · Cited by 59
More Attention and Less Repetitive and Stereotyped Behaviors using a Robot with Children with Autism
Costa, A. P., Charpiot, L., Rodríguez-Lera, F. J., Ziafati, P., Nazarikhorram, A., van der Torre, L., & Steffgen, G. (2018) · IEEE RO-MAN · doi:10.1109/roman.2018.8525747 · Cited by 59
Traumatic brain injury in Brazil: an epidemiological study and systematic review of the literature
Magalhães, A. L. G., BARROS, J. L. V. M. D., CARDOSO, M. G. D. F., Rocha, N. P., Faleiro, R. M., de Souza, L. C., MIRANDA, A. S. D., & Teixeira, A. L. (2022) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 58
Cognitive interventions for memory and psychological well-being in aging and dementias
Dinius, C. J., Pocknell, C. E., Caffrey, M. P., & Roche, R. A. P. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1070012 · Cited by 62
Parkinson's Disease Motor Symptoms in Machine Learning: A Review
Ahlrichs, C., & Lawo, M. (2013) · Health Informatics - An International Journal · doi:10.5121/hiij.2013.2401 · Cited by 63
Direct healthcare cost of schizophrenia – European overview
Kovács, G. L., Almási, T., Millier, A., Toumi, M., Horváth, M., Kóczián, K., Götze, Á., Kaló, Z., & Zemplényi, A. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2017.10.008 · Cited by 64
Metadata
- Authors
- Gustavsson, A., Svensson, M., Jacobi, F., Allgulander, C., Alonso, J., Beghi, E., Dodel, R., Ekman, M., Faravelli, C., Fratiglioni, L., Gannon, B., Jones, D. H., Jennum, P., Jordanova, A., Jönsson, L., Karampampa, K., Knapp, M., Kobelt, G., Kurth, T., Lieb, R., Linde, M., Ljungcrantz, C., Maercker, A., Melin, B., Moscarelli, M., Musayev, A., Norwood, F., Preisig, M., Pugliatti, M., Rehm, J., Salvador-Carulla, L., Schlehofer, B., Simon, R., Steinhausen, H.-C., Stovner, L. J., Vallat, J.-M., den Bergh, P. V., van Os, J., Vos, P., Xu, W., Wittchen, H.-U., Jönsson, B., & Olesen, J.
- Affiliations
- Karlstad University (SE)
- Technische Universität Dresden (DE)
- Karolinska University Hospital (SE)
- Municipal Institute for Medical Research (ES)
- Mario Negri Institute for Pharmacological Research (IT)
- Philipps University of Marburg (DE)
- University of Florence (IT)
- Karolinska Institutet (SE)
- University of Leeds (GB)
- Glostrup Hospital (DK)
- University of Antwerp (BE)
- King's College London (GB)
- Lund University (SE)
- Harvard University (US)
- University of Basel (CH)
- Norwegian University of Science and Technology (NO)
- Umeå University (SE)
- King's College Hospital (GB)
- Centre Hospitalier Universitaire Vaudois (CH)
- University of Sassari (IT)
- German Cancer Research Center (DE)
- European Monitoring Centre for Drugs and Drug Addiction (PT)
- Aalborg University Hospital (DK)
- Centre Hospitalier Universitaire de Limoges (FR)
- Radboud University Nijmegen (NL)
- Stockholm School of Economics (SE)
- Corresponding author
- Olesen, Jes
- ORCID
- Gustavsson, Anders
- Svensson, Mikael
- Jacobi, Frank
- Alonso, Jordi
- Beghi, Ettore
- Dodel, Richard
- Ekman, Mattias
- Fratiglioni, Laura
- Gannon, Brenda
- Jennum, Poul
- Jordanova, Albena
- Jönsson, Linus
- Karampampa, Korinna
- Knapp, Martin
- Kobelt, Gisela
- Kurth, Tobias
- Lieb, Roselind
- Linde, Mattias
- Ljungcrantz, Christina
- Melin, Beatrice
- Moscarelli, Massimo
- Preisig, Martin
- Pugliatti, Maura
- Steinhausen, Hans-Christoph
- Stovner, Lars Jacob
- Vallat, Jean-Michel
- Xu, Weili
- Olesen, Jes
- Venue
- European Neuropsychopharmacology
- Publisher
- Elsevier BV
- Published
- 2011-10
- Volume
- 21
- Issue
- 10
- Pages
- 718-779
- ISSN
- 0924-977X (ISSN-L)
- OpenAlex
- W2131786905
- Cited by
- 1,723
- References
- 427
- Citations by year
- 2026: 42 · 2025: 64 · 2024: 70 · 2023: 88 · 2022: 100 · 2021: 133 · 2020: 123 · 2019: 120 · 2018: 233 · 2017: 130 · 2016: 141 · 2015: 142 · 2014: 124 · 2013: 118 · 2012: 81
- FWCI
- 145.35
- Type
- journal article
- Language
- en
- Open access
- green
- tud.qucosa.de
- Licence
- Locations
- European Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- DIAL (Catholic University of Leuven) (submittedVersion)
- Florence Research (University of Florence) (submittedVersion)
- IRIS (submittedVersion)
- UnissResearch (Università degli Studi di Sassari) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Qucosa (Saxon State and University Library Dresden) (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- mental illness, neurological disorders, economic burden, prevalence, direct and indirect costs, cost model, Europe, brain tumors, dementia, epilepsy, multiple sclerosis, stroke, traumatic brain injury, Parkinson's disease, migraine, developmental disorders, neuromuscular disorders, sleep disorders, somatoform disorders, cost per person
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Mental Disorders, Brain Diseases, Child, Child, Preschool, Europe, Health Expenditures, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Public Health, Prevalence, Health Care Costs, Cost of Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
